Dr. Rudolph Tanzi Makes Presentation at ICAD.
HEALTH AND BEAUTY CLOSE-UP-30 July 2008-Dr. Rudolph Tanzi Makes Presentation at ICAD(C)2008 - CloseUpMedia - newsdesk@closeupmedia.com Breakthrough genetic research to map all the genes connected to Alzheimer's, which could lead to more aggressive treatment and a potential cure for the disease, was the focus of a presentation...

Neuron killers: misfolded, clumping proteins evade conviction, but they remain prime suspects in neurodegenerative diseases.
As open-and-shut cases go, Alzheimer's disease should top the list. The victim is clear. Suspects are in custody. Wherever neurons die due to Alzheimer's disease, a protein known as amyloid-beta is always found at the scene of the crime, hanging around in large, tough gangs called plaques. Parkinson's and...

Jury out on HT's cognitive benefits.
[ILLUSTRATION OMITTED] CHICAGO -- Hormone therapy might preserve cognition and memory in postmenopausal women, and even attenuate some of the cognitive deficits that occur in Alzheimer's disease, new research suggests. Controversy exists over the possible cognitive benefits of hormone therapy in older women, Dr. Mary...

Hormone therapy may benefit cognition, memory.
CHICAGO -- Hormone therapy might preserve cognition and memory in postmenopausal women, and even attenuate some of the cognitive deficits that occur in Alzheimer's disease, new research suggests. Controversy exists over the possible cognitive benefits of hormone therapy in older women, Mary Tierney, Ph.D., said at the...

Imaging and measurements predict status of ad dementia.
CHICAGO -- A combination of specialized brain imaging and cerebrospinal amyloid [[beta].sub.42] measurements powerfully predicts the presence--and absence--of Alzheimer's-type dementia. For several years researchers have focused on A[[beta].sub.42] in cerebrospinal fluid (CSF) as a possible biomarker of Alzheimer's disease (AD): Higher levels indicate the protein is still...

Neuron killers.
Misfolded, clumping proteins evade conviction, but they remain prime suspects in neurodegenerative diseases As open-and-shut cases go, Alzheimer's disease should top the list. The victim is clear. Suspects are in custody. Wherever neurons die due to Alzheimer's disease, a protein known as amyloid-beta is always found at...

Applied NeuroSolutions Selects William Blair & Company as Its Strategic Advisor.
HEALTH AND BEAUTY CLOSE-UP-12 September 2008-Applied NeuroSolutions Selects William Blair & Company as Its Strategic Advisor(C)2008 - CloseUpMedia - newsdesk@closeupmedia.com Applied NeuroSolutions, a biotechnology company focused on the development of products for the early diagnosis and treatment of Alzheimer's disease (AD"), announced that it has engaged William...

Power3 Medical Products Files US Patent Application.
HEALTH AND BEAUTY CLOSE-UP-16 July 2008-Power3 Medical Products Files US Patent Application(C)2008 - CloseUpMedia - newsdesk@closeupmedia.com Power3 Medical Products announced the filing of a US Patent application for the diagnosis of multiple forms of Alzheimer's disease by monitoring a panel of protein biomarkers in human blood serum....

HT may benefit postmenopausal cognition, memory: three new studies contradict past results.
CHICAGO -- Hormone therapy might preserve cognition and memory in postmenopausal women, and even attenuate some of the cognitive deficits that occur in Alzheimer's disease, new research suggests. Controversy exists over the possible cognitive benefits of hormone therapy in older women, Dr. Mary Tierney said at the...

Elan and Wyeth Present Results from Phase 2 Clinical Trial of Bapineuzumab.
HEALTH AND BEAUTY CLOSE-UP-1 August 2008-Elan and Wyeth Present Results from Phase 2 Clinical Trial of Bapineuzumab(C)2008 - CloseUpMedia - newsdesk@closeupmedia.com Elan and Wyeth are presenting detailed results from the companies' 18-month Phase 2 study of bapineuzumab (AAB-001) in patients with mild to moderate Alzheimer's disease at...